We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Court Blocks Cipla From Selling Novartis Generic
Indian Court Blocks Cipla From Selling Novartis Generic
India appears to be working somewhat on its reputation as being unfriendly to foreign drug patents, with a court temporarily blocking Cipla from marketing its own generic version of Novartis’ COPD therapy Onbrez.